The latest price target for OS Therapies (AMEX:OSTX) was reported by D. Boral Capital on February 4, 2025. The analyst firm set a price target for $20.00 expecting OSTX to fall to within 12 months (a possible NaN% downside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for OS Therapies (AMEX:OSTX) was provided by D. Boral Capital, and OS Therapies maintained their buy rating.

There is no last upgrade for OS Therapies

There is no last downgrade for OS Therapies.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OS Therapies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OS Therapies was filed on February 4, 2025 so you should expect the next rating to be made available sometime around February 4, 2026.

While ratings are subjective and will change, the latest OS Therapies (OSTX) rating was a maintained with a price target of $20.00 to $20.00. The current price OS Therapies (OSTX) is trading at is $undefined, which is out of the analyst’s predicted range.